RT @HTAcamfic: 📍Tiazides: Una nova revisió de la @cochranecollab conclou que disminuirien els esdeveniments cardiovasculars, encara que no…
RT @HTAcamfic: 📍Tiazides: Una nova revisió de la @cochranecollab conclou que disminuirien els esdeveniments cardiovasculars, encara que no…
📍Tiazides: Una nova revisió de la @cochranecollab conclou que disminuirien els esdeveniments cardiovasculars, encara que no la mortalitat total, en comparació amb la resta d'antihipertensius (ISRA, BB, BCC i AB), mantenint la mateixa seguretat. https://t.c
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @JuanGrvas: ¿Hipertensión? Que no le engañen: los mejores medicamentos son los diuréticos, los más baratos, los clásicos. First‐line di…
RT @JuanGrvas: ¿Hipertensión? Que no le engañen: los mejores medicamentos son los diuréticos, los más baratos, los clásicos. First‐line di…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @JuanGrvas: ¿Hipertensión? Que no le engañen: los mejores medicamentos son los diuréticos, los más baratos, los clásicos. First‐line di…
¿Hipertensión? Que no le engañen: los mejores medicamentos son los diuréticos, los más baratos, los clásicos. First‐line diuretics versus other classes of antihypertensive drugs for hypertension. https://t.co/BAffjpbTLe https://t.co/cnrYwX3pVl
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20 studies that randomized more than 90,000 people: https://t.co/fe9EE5Rs0n #CochraneEvidence #SystematicReview #prescribing #HighBloodP
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @EARL_med_tw: 🔗論文リンク https://t.co/AeoWA3sd0c
🔗論文リンク https://t.co/AeoWA3sd0c
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
@SAHTA_Sociedad
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20 studies that randomized more than 90,000 people: https://t.co/fe9EE5Rs0n #CochraneEvidence #SystematicReview #prescribing #HighBloodP
RT @CochraneFrance: ❓Quels sont les bénéfices et les risques des diurétiques de première intention par rapport à d'autres classes de d'autr…
RT @CochraneFrance: ❓Quels sont les bénéfices et les risques des diurétiques de première intention par rapport à d'autres classes de d'autr…
❓Quels sont les bénéfices et les risques des diurétiques de première intention par rapport à d'autres classes de d'autres classes d'antihypertenseurs pour l'hypertension ? 🔎Revue @CochraneHTN évaluant 20 études portant sur + de 90000 personnes 🔗Résumé : ht
First‐line diuretics versus other classes of antihypertensive drugs for hypertension https://t.co/BcbfY18hxC
RT @nitrotake: なるほど。高血圧に対する1stの件、改めてポストが学びとなりました。 https://t.co/PEOjQt1BdV
RT @nitrotake: なるほど。高血圧に対する1stの件、改めてポストが学びとなりました。 https://t.co/PEOjQt1BdV
RT @nitrotake: なるほど。高血圧に対する1stの件、改めてポストが学びとなりました。 https://t.co/PEOjQt1BdV
なるほど。高血圧に対する1stの件、改めてポストが学びとなりました。 https://t.co/PEOjQt1BdV
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20 studies that randomized more than 90,000 people: https://t.co/fe9EE5Rs0n #CochraneEvidence #SystematicReview #prescribing #HighBloodP
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20 studies that randomized more than 90,000 people: https://t.co/fe9EE5QUaP #CochraneEvidence #SystematicReview #prescribing #HighBloodP
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @Fizz_DI: 「サイアザイド系利尿薬」は、その他の降圧薬に比べ、総死亡の点で差はなく、心血管イベントや副作用による離脱等の一部において利点がありそう、というレビュー。 Cochrane Database Syst Rev . 2023 Jul 13;7(7):CD…
「サイアザイド系利尿薬」は、その他の降圧薬に比べ、総死亡の点で差はなく、心血管イベントや副作用による離脱等の一部において利点がありそう、というレビュー。 Cochrane Database Syst Rev . 2023 Jul 13;7(7):CD008161. PMID:37439548 https://t.co/Zlljy7oVKn
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
RT @CochraneHTN: ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20…
ICYMI: #hypertension review alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20 studies that randomized more than 90,000 people: https://t.co/fe9EE5Rs0n #CochraneEvidence #SystematicReview #prescribing #HighBloodP
RT @familymedicine0: 【高血圧症の治療1stはやはりサイアザイド】 ・コクランレビュー ・サイアザイドは、β遮断薬、カルシウム拮抗薬、ACE阻害薬、α遮断薬と比較すると、総死亡率に変化はないが、心血管イベントや副作用による離脱などの罹患率を低下させる可能性が…
【高血圧症の治療1stはやはりサイアザイド】 ・コクランレビュー ・サイアザイドは、β遮断薬、カルシウム拮抗薬、ACE阻害薬、α遮断薬と比較すると、総死亡率に変化はないが、心血管イベントや副作用による離脱などの罹患率を低下させる可能性が高い。 https://t.co/O6ix2SXTnt
RT @CochraneHTN: 🆕#hypertension publication alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20 s…
RT @CochraneHTN: 🆕#hypertension publication alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20 s…
1st line diuretics show reduced cardiovascular events, comparable mortality vs. other antihypertensive drugs. 👇👇 https://t.co/0DaMixLmzW
RT @CochraneHTN: 🚨#hypertension publication alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on benefits/harms of first-line #diuretics considers…
RT @CochraneHTN: 🚨#hypertension publication alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on benefits/harms of first-line #diuretics considers…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneLibrary: What are the benefits & harms of #diuretics given as a first treatment compared to other drug classes for #hypertensio…
RT @CochraneLibrary: What are the benefits & harms of #diuretics given as a first treatment compared to other drug classes for #hypertensio…
RT @BITNavarra: Los diuréticos no son superados como primera línea para la hipertensión.
RT @CochraneLibrary: What are the benefits & harms of #diuretics given as a first treatment compared to other drug classes for #hypertensio…
What are the benefits & harms of #diuretics given as a first treatment compared to other drug classes for #hypertension / #highbloodpressure? 📚 🔍 @CochraneHTN looked at the evidence from 20 studies with over 90,000 people. https://t.co/81jH56l3Tw
RT @Ghanavati_r: #CardioEBM 🧵 #CardioTwitter #MedTwitter #hypertension #SRMA 1/n #Diuretics take back 1️⃣ place as BP lowering💊 🚨 Mainly b…
#CardioEBM 🧵 #CardioTwitter #MedTwitter #hypertension #SRMA 1/n #Diuretics take back 1️⃣ place as BP lowering💊 🚨 Mainly by ⬇️in Adverse Event (AE)🚨 ⚠️No clear benefit of other 💊 over diuretics⚠️ @CochraneLibrary @ubcpharmacy https://t.co/XHgNfQYk0Q
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 8/ Implications for research: Future head‐to‐head trials (H2H) assessing mortality/morbidity should incl an arm with 1st‐…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
RT @CochraneHTN: 🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systemati…
8/ Implications for research: Future head‐to‐head trials (H2H) assessing mortality/morbidity should incl an arm with 1st‐line low‐dose thiazides Need independent, large, long‐duration H2H trials comparing 1st‐line thiazides with ARBs & renin inhibito
6/ Main results continued: ✅Diuretics likely↘️total CVEs, heart failure compared to CCBs or alpha‐blockers ✅Diuretics likely↘️withdrawals from studies due to unwanted or harmful effects compared to beta‐blockers, CCBs, ACE inhibitors, alpha‐blockers 👉🏽ht
3/ Trial selection criteria: ✅ randomized controlled trials (RCTs) ✅ duration of at least one year ✅ morbidity and mortality data comparing first‐line diuretics head‐to‐head with one or more other first‐line antihypertensive therapies 👉🏽https://t.co/v2xz2
2/ The author team & information specialist searched for studies that: ✅ Included people with elevated #bloodpressure ✅ Examined benefits/harms of #diuretics compared to other first-line antihypertensive drug classes 👉🏽https://t.co/v2xz2Q4P0y #Hyper
🧵 First‐line #diuretics vs other classes of antihypertensives for #hypertension 1/ In this new @CochraneLibrary systematic review, we wanted to know if benefits/harms of diuretics given first for high #bloodpressure differed from other drug classes: https
📢 Thiazide diuretics show promising results against beta-blockers, calcium channel blockers, ACE inhibitors, and alpha-blockers. Similar mortality, reduced cardiovascular events, stroke, CHD, and heart failure. Fewer adverse effects and withdrawals. #Hyper
RT @CochraneHTN: 🆕#hypertension publication alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20 s…
RT @CochraneHTN: 🆕#hypertension publication alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on first-line #diuretics considers evidence from 20 s…
RT @CochraneHTN: 🚨#hypertension publication alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on benefits/harms of first-line #diuretics considers…
RT @CochraneHTN: 🚨#hypertension publication alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on benefits/harms of first-line #diuretics considers…
RT @CochraneHTN: 🚨#hypertension publication alert!🚨 🔍🧑🏽💻Our @CochraneLibrary review on benefits/harms of first-line #diuretics considers…
RT @BITNavarra: Los diuréticos no son superados como primera línea para la hipertensión.